Skip to main content Skip to navigation

Meet our People

Sian Taylor-Phillips

Professor Sian Taylor Phillips Professor in Public Health

Co-director of Warwick Screening and WaMB-ESG.

Sian is a Professor of Population Health at Warwick Medical School, University of Warwick, specialising in evaluation of medical tests and screening programmes. I lead Warwick Screening, a team of researchers who synthesise evidence for national policy-makers, and deliver primary research across several screening programmes. In addition, I am a member of the UK National Screening Committee and provide expertise to help shape the committee’s recommendations to the four UK governments.

Dr Chris Stinton

Associate Professor

Chris is Lead of WaMB-ESG and Associate Professor at Warwick Medical School. He specialises in health screening and evidence synthesis, with particular interests in test accuracy, human factors in screening, and the ethics of screening. He is co-lead for Warwick University’s Health Screening Module (a collaboration between Warwick Screening and the UK National Screening Committee) and teaches the ethics of health screening. He has conducted reviews for the UK National Screening Committee, the World Health Organisation, and the National Institute for Health and Care Excellence. He is a member of the UK National Screening Committee’s Adults Reference Group.

 

https://orcid.org/0009-0003-2419-7688

Dr Karoline Freeman

Associate Professor

Karoline is an Associate Professor in quantitative analysis of breast cancer screening. Her current research focuses on evidence synthesis in health screening using systematic review methodology, observational data and trials to inform national policy advisors on test use and changes to screening programmes.

Karoline is a member of the NHS Research Innovation and Development Advisory Committee and the UK NSC Breast Working Group.

Karoline is module co-lead on the master level Health Screening module and supervises PhD students in beast screening research and MPH students undertaking their final year projects.

Hannah Williams

Screening WaMB-ESG
Programme Manager and Project Manager

Hannah Williams is the project manager for WaMB-ESG. She has managed a number of projects within Warwick Screening and experience working as a researcher in the field of health screening.


Yemisi Takwoingi

Professor of Test Evaluation and Evidence Synthesis and Head of Department of Applied Health Sciences at the University of Birmingham, UK

A biostatistician/methodologist on diagnostic research spanning early phase evaluation, clinical studies, and evidence synthesis to inform guideline development. Yemisi co-convenes the Cochrane Screening and Diagnostic Tests Methods Group, serves on the Cochrane Editorial Board, and is an editor of the Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy. She leads capacity development for the NIHR West Midlands Evidence Synthesis Group (ESG) and the Warwick-Birmingham-Manchester Screening

(WaMB-ESG) ESG.

Julia Geppert

Research Fellow

Julia is a systematic reviewer with particular interest in the evaluation of screening tests and programmes. She contributes to evidence reviews for the UK National Screening Committee, Cochrane, Cancer Research UK and NICE since 2014.

 Julia Geppert

Julia Geppert - Research Fellow at University of Warwick | LinkedIn

Julia Geppert (0000-0001-6446-6094) - ORCID

Catherine Mitchell

Research Fellow

Catherine has over 12 years’ experience conducting systematic literature reviews (SLRs) across a wide range of therapeutic areas, including diabetes, cardiology, oncology, rare diseases, and more. She has led clinical, epidemiology, economic, QoL, and pre-clinical reviews to support HTA submissions, regulatory filings, and publications. Catherine holds a PhD from University College London, a BSc (Hons) in Biological Sciences from the University of Edinburgh, and completed postdoctoral research at Columbia University in New York

LinkedIn profile linkedin.com/in/catherine-mitchell-418a1275

Eileen Taylor

Project Officer

Eileen is Project Officer within the

WaMB-ESG and Screening team. She has been at the University of Warwick for over 20 years having worked within Education and over 10 years of experience across various research teams.

Felicity Boardman

Professor

Felicity is a professor of social science in medicine. Her work focuses on the social and ethical implications of screening programmes, with a particular interest in genomic technologies and rare disease.

Twitter: https://x.com/imaginingfuture

Academic profile: https://warwick.ac.uk/fac/sci/med/staff/fboardman

Linkedin: https://www.linkedin.com/in/felicity-boardman-011b72346/

Jac Dinnes

Senior Research Fellow

Dr Jac Dinnes is a Senior Research Fellow at the Department of Applied Health Sciences at the University of Birmingham. She is a methodologist with a large and sustained portfolio of systematic reviews and publications from methodological projects related to the evaluation of diagnostic tests. She is a deputy theme lead for the Data, Diagnostics and Decision Tools theme at the NIHR Birmingham Biomedical Centre and a project lead for the NIHR West Midlands Evidence Synthesis Group (WM-ESG) and Warwick-Birmingham - Manchester Screening Evidence Synthesis Group (WaMB-ESG).

Sophie Staniszewska

Professor

Sophie is the lead for PPIE for the NIHR West Midlands Evidence Synthesis Group, PPIE advisor to the NIHR Screening ESG, PPIE co-lead For the NIHR Health Determinants Research Collaboration in Coventry and PPIE research lead for the NIHR Applied Research Collaboration West Midlands. Until recently Sophie was PPIE lead for the NIHR Health Protection Research Unit for Gastrointestinal Research, the NIHR Health Protection Research Unit in Genomics and Enabling Data.

Pooja Kumar

Research Associate

Pooja is a Research Associate within the WaMB-ESG
team, contributing to multiple reviews for the UK National Screening Committee (UKNSC). She holds Bachelor’s and Master’s degrees in Audiology and completed her Master’s in Public Health at the University of Edinburgh, and is expanding her expertise in research to support high-quality policy-relevant work.

 

(1) Pooja Suresh Kumar | LinkedIn

Amy Gamble

Research Fellow

Amy is a Research Fellow at the University of Birmingham with a background in systematic reviewing. I am currently working on evidence synthesis projects for the NIHR Warwick-Birmingham -Manchester Screening ESG to support UK screening policy.

 

LinkedIn: www.linkedin.com/in/amy-gamble-338931196 

Matthew Randell

Matthew is a research assistant working part-time with Warwick Screening and WaMB-ESG. His role includes systematic reviewing, ethics, and supporting public & patient involvement & engagement.

Alongside this, Matthew is nearing completion of his PhD in the social and ethical implications of paediatric screening for type 1 diabetes. His broader research interests include screening for future disease that cannot yet be prevented, and how ethical analysis is operationalised in policy making.

ORCID: https://orcid.org/0000-0001-5856-3007

Samantha Johnson

Research and Academic Support Librarian

Sam is the Information Specialist for WaMB-ESG. She has 20 years’ experience of working with various researchers and students at Warwick, providing support and training in developing and running systematic literature searches, reference management and research support. She splits this role with being one of the Research and Academic Support Librarians for the Medical School, School of Life Sciences and Psychology.

 

ORCID: https://orcid.org/0000-0002-4716-1229

Amy Grove

Psychologist and Professor of Implementation Science

Amy is a Psychologist and Professor of Implementation Science. As a leading methodologist, she evaluates health technology and innovation to directly impact health service design and delivery.

Dr Corinna Clark

Assistant Professor

Corinna is a reviewer and the PPIE lead for the WaMB-ESG. She is an experienced mixed methodologist with a background in epidemiology. She has research interests in the social and ethical implications of using genetic technologies in healthcare, particularly in relation to screening, and the practice and implementation of public, patient and community involvement and engagement.

 

Bluesky @corinnaclark.bsky.social

LinkedIn https://www.linkedin.com/in/corinna-clark-86808096/

Profile

https://profiles.warwick.ac.uk/lfsnaq-corinna-clark

Professor Aileen Clarke

Emeritus Professor of Public Health & Health Services Research, University of Warwick

Professor Aileen Clarke provides quality assurance support for WaMB-ESG. An internationally recognised public health academic and clinician, she has over 30 years' experience in evidence synthesis, screening, health services research and implementation science. Alongside her role at Warwick, she is Clinical Professor at the University of Birmingham and holds honorary research positions within the University of Oxford.

Aileen Clarke MD FRCGP FFPH

 


Dr Stuart Wright

Senior Research Fellow in Health Economics and Principal Investigator in the Manchester Breast Centre

Dr Stuart Wright is a Senior Research Fellow in Health Economics and Principal Investigator in the Manchester Breast Centre. Stuart's main research interest relates to the economics of cancer, with a particular focus on the cost-effectiveness of cancer screening programmes. He is involved in a range of model-based cost-effectiveness evaluations, particularly around interventions to improved detection of cancers that primarily affect women (breast, cervical, and endometrial cancer). He is also interested in understanding public preferences for changes to cancer screening programmes to help improve service design to increase uptake. Stuart is also a member of the Adult Reference Group of the National Screening Committee.

Professor Katherine Payne

Professor of Health Economics, based in the Manchester Centre for Health Economics, The University of Manchester.

Katherine is a Professor of Health Economics, based in the Manchester Centre for Health Economics, The University of Manchester. Katherine is a NIHR Senior Investigator.

Katherine has applied and methodological research experience in the economic evaluation (using RCT and decision-analytic models) and valuation (using discrete choice experiments and contingent valuation) of health care interventions and specifically precision medicine, genomics and screening. She is a (co-opted) member of the UK National Screening Committee.

Ania

Bobrowska

Title

 

LinkedIn

Profile


Let us know you agree to cookies